For Investors

Preliminary consolidated sales results of AS Olainfarm for January of 2018 show that sales have reached 9.19 million euros, which is comparable to the sales volume demonstrated in January of 2017. The biggest sales increase was achieved in Uzbekistan, where sales grew by 237%. Sales to Ukraine grew by 222%, but sales to Kazakhstan increased by 131%. The biggest sales reductions were experienced in The Netherlands, where sales shrunk by 89% and Poland, where sales shrunk by 40%. Major sales markets of Olainfarm group in January of 2018 were Latvia, Russia, Belarus and Ukraine. Products of the group were sold to 31 countries.

January 2018, consolidated sales

Sales, Thsnd. EUR

Changes to January 2017

Share in total sales

Latvia

2 922

18%

32%

Russia

1 716

-27%

19%

Belarus

1 696

5%

18%

Ukraine

1 107

222%

12%

Kazakhstan

249

131%

3%

Germany

210

4%

2%

Poland

172

-40%

2%

Uzbekistan

171

237%

2%

Lithuania

145

-13%

2%

The Netherlands

97

-89%

1%

Other

705

2%

8%

Total

9 190

0%

100%

Sales numbers of daughter companies of JSC Olainfarm that provide significant impact on consolidated results show that sales of Latvijas Aptieka in January reached 2.03 million euros, which represents an increase by 18% compared to January of 2017. Sixty-nine pharmacies were operating during January. Sales of Silvanols during this period were 0.42 million euros, which represents a reduction by 16%. Combined sales of Tonus Elast and its Russian based distributor Elast Medical reached 0.52 million euros. Combined sales of medical companies Diamed and Olainmed reached 0.2 million euros, while sales of Belarus based company NPK Biotest also reached 0.2 million euros.

January, 2018

Sales markets of Olainfarm

27

Sales markets of the Group

31

Number of pharmacies of Latvijas Aptieka

69

Sales of Latvijas Aptieka

€ 2 026 519

Combined sales of Olainmed and Diamed

€ 197 000

Sales of NPK Biotest

€ 196 028

Combined sales of Tonus Elast and Elast Medical

€ 515 252

Sales of Silvanols

€ 418 216

According to unconsolidated preliminary results, sales of JSC Olainfarm in January 2018 reached 7.1 million euros, which represents a reduction by 9% compared to the same period of 2017. Biggest sales increase was achieved in Uzbekistan, where sales grew by 237%. Sales to Ukraine grew by 222%, but sales to Kazakhstan grew by 175%. The biggest sales reduction was experienced in The Netherlands, where sales shrunk by 89%. Major sales markets during January were Belarus, Latvia, Russia and Ukraine. In total products of Olainfarm were sold to 27 countries.

January 2018, unconsolidated sales

Sales, Thsnd, EUR

Changes to January 2017

Share in total sales

Belarus

1 500

-7%

21%

Latvia

1 498

16%

21%

Russia

1 486

-36%

21%

Ukraine

1 107

222%

16%

Kazakhstan

234

175%

3%

Germany

207

5%

3%

Uzbekistan

171

237%

2%

Lithuania

137

-4%

2%

Poland

133

-50%

2%

The Netherlands

97

-89%

1%

Other

529

-6%

7%

Total

7 099

-9%

100%

Preliminary sales targets of JSC Olainfarm for 2018 are being finalized, therefore the percentages of achieved sales targets will be provided beginning with the next monthly sales reports, once budgets for 2018 are approved.

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 50 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

Preliminary consolidated results of JSC Olainfarm for December 2017 show that sales have reached 10.08 million euros, which represents a reduction by 2% compared to December 2016. The biggest sales increase was achieved in Ukraine, where sales grew by 700%, and in Belarus, where sales increased by 329%. The biggest sales reduction was experienced in Kyrgyzstan, where sales shrunk by 36%, while sales to Kazakhstan shrunk by 32%. During December 2017, significant shipments were also made to Uzbekistan. Major sales markets of Olainfarm group during December 2017 were Russia, Latvia and Ukraine.

December 2017, consolidated sales

Sales, thsnd. EUR

Changes to December 2016

Share in total sales

Russia

4 471

-12%

44%

Latvia

2 682

-2%

27%

Ukraine

840

700%

8%

Belarus

307

329%

3%

Tajikistan

218

-15%

2%

Kazakhstan

193

-32%

2%

Uzbekistan

176

NA

2%

Lithuania

126

19%

1%

Georgia

124

-7%

1%

Kyrgyzstan

113

-36%

1%

Other

826

-39%

8%

Total

10 076

-2%

100%

Sales of pharmacy chain of Latvijas aptieka during December 2017 were 2 million euros, which represents an increase by 21% compared to sales this company made in December 2016. Sixty-nine pharmacies were operating during this period. Sales of Silvanols during December 2017 were 0.4 million euros, which represents a reduction by 18% compared to December 2016. During December, Silvanols sold its products to nine European countries and with the help of JSC Olainfarm also to Belarus, Russia, Azerbaijan and Kosovo. Sales of Tonus Elast during December 2017 were 0.8 million euros, which represents a reduction by 26% compared to December 2016. The sales were made to 21 countries in three continents.

According to preliminary numbers, consolidated sales of JSC Olainfarm in 2017 reached 114.04 million euros, which represents an increase by 4% compared to 2016. The biggest sales increases have been achieve in Germany, where sales grew by 103% and The Netherlands, where sales grew by 57%. Biggest sales reductions were experienced in Ukraine, Where sales shrunk by 21% and Uzbekistan, where sales shrunk by 15%. Major sales markets of Olainfarm group in 2017 were Russia, Latvia, Ukraine and Belarus. Companies of the group made sales to 61 countries in five continents.

Consolidated sales, 2017

Sales, Thsnd. EUR

Changes to 2016

Share in total sales

Russia

39 850

6%

35%

Latvia

28 492

7%

25%

Ukraine

10 936

-21%

10%

Belarus

8 939

21%

8%

The Netherlands

3 856

57%

3%

Kazakhstan

3 116

-2%

3%

Uzbekistan

1 869

-15%

2%

Germany

1 718

103%

2%

Lithuania

1 508

13%

1%

Poland

1 376

-5%

1%

Other

12 382

-5%

11%

Total

114 042

4%

100%

Sales of Latvijas aptieka in 2017 reached 21.6 million euros, which represents an increase by 16% compared to 2016. Sales of Silvanols in 2017 were 5.2 million euros, which represents a reduction by 3% compared to 2016, where sales of Silvanols were 5.4 million euros. Products of Silvanols were sold to twelve European countries and with the help of JSC Olainfarm also to Kazakhstan, Lithuania, Belarus, Russia, Armenia, Mongolia, Kosovo and Azerbaijan. Sales of Tonus Elast in 2017 were 8.5 million euros, and its products were sold to 38 countries in four continents.

According to preliminary unconsolidated data, sales of JSC Olainfarm in December 2017 were 8.08 million euros, which represents an increase by 4% compared to December 2016. The biggest sales increase was achieved in Ukraine, where sales grew by 625%. Sales to Belarus increased by 382%, while sales to Lithuania increased by 50%. The biggest sales reduction was experienced in Kazakhstan where sales shrunk by 54%. During December 2017, JSC Olainfarm also made significant shipments to Uzbekistan and Bulgaria. The biggest sales markets of JSC Olainfarm in December 2017 were Russia, Latvia and Ukraine. In total during this period, products of JSC Olainfarm were sold to 28 countries.

December 2017, unconsolidated sales

Sales, Thsnd. EUR

Changes to December 2016

Share in total sales

Russia

4 181

-11%

52%

Latvia

1 410

20%

17%

Ukraine

761

625%

9%

Belarus

245

382%

3%

Tajikistan

212

-13%

3%

Uzbekistan

176

NA

2%

Lithuania

120

50%

1%

Kazakhstan

112

-54%

1%

Bulgaria

104

NA

1%

Kyrgyzstan

99

-26%

1%

Other

655

-36%

8%

Total

8 075

4%

100%

According to preliminary unconsolidated results, sales of JSC Olainfarm in 2017 reached 91.97 million euros, which is comparable to the sales company made in 2016. The biggest sales increase in 2017 was achieved in Germany, where sales grew by 100%, while sales to The Netherlands increased by 57%. The biggest sales reduction was experienced in Ukraine, where sales shrunk by 28%. The major sales markets of JSC Olainfarm during this period were Russia, Latvia, Ukraine and Belarus. In total during 2017 products of JSC Olainfarm were sold to 51 countries in five continents.

2017, unconsolidated sales

Sales, thsnd. EUR

Changes to 2016

Share in total sales

Russia

36 471

1%

40%

Latvia

14 815

10%

16%

Ukraine

10 655

-28%

12%

Belarus

8 764

20%

10%

The Netherlands

3 856

57%

4%

Kazakhstan

2 094

-19%

2%

Uzbekistan

1 869

-15%

2%

Germany

1 670

100%

2%

Lithuania

1 281

16%

1%

Turkmenistan

1 246

17%

1%

Other

9 247

-8%

10%

Total

91 968

0%

100%

General meeting of shareholders of JSC Olainfarm held on June 1, 2017 approved operating plan of the company, providing that unconsolidated sales of the company in 2017 will reach 96 million euros, while consolidated sales of the company will reach 127 million euros. According to these preliminary sales numbers, in 2017 the company has met 96% of annual target for unconsolidated sales and 90% of annual target for consolidated sales.

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 50 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

On January 11 JSC Olainfarm organized its Investor Conference Online Webinar. During the webinar the member of the management board of JSC Olainfarm Salvis Lapiņš analyzed the financial results of third quarter 2017 and informed about the other recent activities within the company.

During the webinar, Salvis Lapiņš received a question on the amount of receivables overdue for 90 and more days that are unprovided for. The amount totaled 1.4 million euros as of October 1st, 2017.

Olainfarm thanks all participants, who joined the webinar, and encourages everybody to follow company’s announcements to get information on the next webinar!

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 50 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

What is a webinar?
Webinar is a virtual conference, during which company’s representative gives information about the company, its activities and future plans. Webinar allows interactive communication and provides an opportunity to ask questions and get answers directly from the company.

How to join the webinar?
All you need is a computer with internet connection and headphones.

You will be provided with the webinar link and instructions to join webinar successfully. When joining the webinar for the first time, you will be asked to download the system application on your computer which will take only few seconds. For more information on webinar service please visit: http://www.nasdaqbaltic.com/en/products-services/webinars-3/

Join the webinar and be the first one to hear the news!

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 50 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.
Information prepared by:
Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

Preliminary consolidated results of JSC Olainfarm for November 2017 show that total sales of the company have reached 10.07 million euros, which represents a reduction by 10% compared to the same period of 2016. The biggest sales increase has been achieved in Ukraine, where it increased by 209%. Sales to Kyrgyzstan increased by 149%, but sales to Uzbekistan increased by 133%. Biggest sales reduction took place in Kazakhstan, where they shrunk by 65%. During November 2017 JSC Olainfarm also made significant shipments to Turkmenistan. Major sales markets of the Group during November 2017 were Russia, Latvia and Ukraine.

November 2017, consolidated sales

Sales, thsnd. EUR

Changes to November 2016

Share in total sales

Russia

3 563

-33%

35%

Latvia

2 643

5%

26%

Ukraine

1 542

209%

15%

Belarus

520

14%

5%

Uzbekistan

297

133%

3%

Kazakhstan

191

-65%

2%

Germany

158

36%

2%

Turkmenistan

143

NA

1%

Lithuania

122

-25%

1%

Kyrgyzstan

116

149%

1%

Other

771

-45%

8%

Total

10 066

-10%

100%

Sales of Latvijas aptieka during November were 1.9 million euros, which represents an increase by 18% compared to November of 2016. Sixty – nine pharmacies were operating during this period. Sales of Silvanols in November 2017 were 0.46 million euros, which represents a reduction by 28% compared to the same period of last year. During November, Silvanols was selling its products to nine European countries and with the assistance from JSC Olainfarm also to Belarus, Russia, Azerbaijan and Kosovo. Sales of Tonus Elast during November 2017 were 0.9 million euros, which represents an increase by 15% compared to November 2016. Its products were sold to 20 countries in three continents.

According to preliminary consolidated results sales of eleven months of 2017 reached 105.19 million euros, which represents an increase by 5% compared to eleven months of 2016. The biggest sales increase during this period was achieved in Germany, where sales grew by 106%, while sales to The Netherlands increased by 92%. The biggest sales reduction was experienced in Ukraine, where sales shrunk by 27%. Major sales markets of the Group during this period were Russia, Latvia, Ukraine and Belarus. Products of the group were sold to 61 countries in five continents.

11 months of 2017, consolidated sales

Sales, thsnd. EUR

Changes to 11 months of 2016

Share in total sales

Russia

35 379

9%

34%

Latvia

26 994

12%

26%

Ukraine

10 096

-27%

10%

Belarus

8 734

19%

8%

The Netherlands

3 856

92%

4%

Kazakhstan

2 923

0%

3%

Germany

1 712

106%

2%

Uzbekistan

1 694

-23%

2%

Lithuania

1 382

14%

1%

Poland

1 281

-3%

1%

Other

11 138

-5%

11%

Total

105 189

5%

100%

During eleven months period, sales of Latvijas aptieka reached 19.6 million euros, which represents an increase by 15% compared to the same period of last year. Sales of Silvanols during this period shrunk by 4% and reached 4.7 million euros. Silvanols sold its products to twelve European countries and with assistance from JSC Olainfarm also to Kazakhstan, Lithuania, Belarus, Russia, Armenia, Mongolia, Kosovo and Azerbaijan. Sales of Tonus Elast during eleven months were 7.7 million euros, and its products were sold to 38 countries in four continents.

According to preliminary unconsolidated results, sales of JSC Olainfarm during November 2017 reached 7.97 million euros, which represents a reduction by 12% compared to November 2016. The biggest sales increase during this period was achieved in Ukraine, where sales grew by 223%. Sales to Uzbekistan increased by 133%, sales to Kyrgyzstan increased by 104%. The biggest sales reduction during November was experienced in Kazakhstan, where sales shrunk by 76%. During November 2017, JSC Olainfarm also made significant shipments to Turkmenistan. Major sales markets of JSC Olainfarm during this period were Russia, Ukraine, Latvia and Belarus. In total products of Olainfarm were sold to 23 countries in Europe and Asia.

November 2017, unconsolidated sales

Sales, thsnd. EUR

Changes to November 2016

Share in total sales

Russia

3 194

-37%

40%

Ukraine

1 542

223%

19%

Latvia

1 370

9%

17%

Belarus

502

13%

6%

Uzbekistan

297

133%

4%

Turkmenistan

143

NA

2%

Germany

137

22%

2%

Lithuania

118

-14%

1%

Kazakhstan

115

-76%

1%

Kyrgyzstan

95

104%

1%

Other

454

-52%

6%

Total

7 967

-12%

100%

According to preliminary unconsolidated results, sales of JSC Olainfarm in eleven months of 2017 were 84 million euros, which represents a reduction by 1% compared to eleven months of 2016. The biggest sales increase during this period was achieved in Germany, where sales grew by 103% and The Netherlands, where the sales grew by 92%. The biggest sales reduction was experienced in Ukraine, where sales shrunk by 27% and Uzbekistan, where sales shrunk by 23%. Major sales markets of JSC Olainfarm during this period were Russia, Latvia, Ukraine and Belarus. In total during eleven months period products of JSC Olainfarm were sold to 50 countries in five continents.

11 months of 2017, unconsolidated sales

Sales, thsnd. EUR

Changes to 11 months of 2016

Share in total sales

Russia

32 290

3%

38%

Latvia

13 404

9%

16%

Ukraine

9 894

-27%

12%

Belarus

8 622

19%

10%

The Netherlands

3 856

92%

5%

Kazakhstan

1 982

-15%

2%

Uzbekistan

1 694

-23%

2%

Germany

1 665

103%

2%

Turkmenistan

1 167

9%

1%

Lithuania

1 161

13%

1%

Other

8 261

-9%

10%

Total

83 996

1%

100%

General meeting of shareholders of JSC Olainfarm held on June 1, 2017 approved operating plan of the company, providing that unconsolidated sales of the company in 2017 will reach 96 million euros, while consolidated sales of the company will reach 127 million euros. According to these preliminary sales numbers, in eleven months of 2017 the company has met 88% of annual target for unconsolidated sales and 83% of annual target for consolidated sales.

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 50 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

Preliminary consolidated results of JSC Olainfarm for October 2017 show that company’s sales have reached 9.51 million euros, which represents reduction by 7% compared to the same period of 2016. The biggest sales increase during this period was achieved in Poland, where it grew by 623%. Sales to Moldova increased by 180%. Significant shipments during this period were also made to Tajikistan. Major sales markets of Olainfarm group during October 2017 were Russia, Latvia and Ukraine.

October 2017, consolidated sales

Sales, thsnd. EUR

Changes to October 2016

Share in total sales

Russia

3 434

-18%

36%

Latvia

2 754

18%

29%

Ukraine

1 143

3%

12%

Belarus

518

-5%

5%

Germany

249

-11%

3%

Poland

216

623%

2%

Tajikistan

176

NA

2%

Moldova

149

180%

2%

Lithuania

136

40%

1%

Georgia

105

7%

1%

Other

630

-55%

7%

Total

9 510

-7%

100%

Sales of pharmacies of Latvijas aptieka in October 2017 were 2.02 million euros, which represents an increase by 25% compared to the same period of last year. Sixty-nine pharmacies were operating during October. Sales of Silvanols in October 2017 were 0.4 million euros, which represents a reduction by 25% compared to the same period of 2016. Silvanols was selling its products in six European countries. Sales of Tonus Elast in October were 0.62 million euros, which represents a reduction by 29% compared to October 2016. Tonus Elast sold its products in 15 countries in three continents.

In ten months of 2017, according to the preliminary results, the consolidated sales of JSC Olainfarm reached 95.11 million euros, which represents an increase by 7% compared to ten months of 2016. The biggest sales increase during this period was achieved in Germany, where sales increased by 118%. Sales to The Netherlands increased by 92%. Biggest sales reduction took place in Ukraine, where sales shrunk by 35%. The major sales markets of Olainfarm group during this period were Russia, Latvia, Ukraine and Belarus.

10 months of 2017, consolidated sales

Sales, thsnd. EUR

Changes to 10 months of 2016

Share in total sales

Russia

31 816

17%

33%

Latvia

24 359

13%

26%

Ukraine

8 554

-35%

9%

Belarus

8 214

20%

9%

The Netherlands

3 831

92%

4%

Kazakhstan

2 733

16%

3%

Germany

1 554

118%

2%

Uzbekistan

1 397

-33%

1%

Lithuania

1 265

15%

1%

Poland

1 222

11%

1%

Other

10 168

-3%

11%

Total

95 113

7%

100%

Sales of pharmacies of Latvijas aptieka in 10 months of 2017 reached 17.7 million euros, which represents an increase by 14% compared to ten months of 2016. Sales of Silvanols during this ten months period have reached 4.3 million euros, which represents an increase by 2%. Products of Silvanols are sold to twelve European countries. Sales of Tonus Elast in ten months was 6.8 million euros, and the company sold its products to 37 countries in four continents.

According to unconsolidated preliminary results, sales of JSC Olainfarm in October 2017 were 7.63 million euros, which represents a reduction by 5% compared to October 2016. The biggest sales increase was achieved in Poland, where sales grew by 552%. Sales to Lithuania increase by 58%. During October 2017, the company also made significant shipments to Tajikistan and Albania. Biggest sales reduction was experienced in Kazakhstan, where sales shrunk by 35%. Major markets of the company during October 2017 were Russia, Latvia, Ukraine and Belarus. During October 2017 JSC Olainfarm sold its products to 27 countries in two continents.

October 2017, unconsolidated sales

Sales, thsnd. EUR

Changes to October 2016

Share in total sales

Russia

3 151

-18%

41%

Latvia

1 447

33%

19%

Ukraine

1 125

3%

15%

Belarus

518

-1%

7%

Germany

236

-16%

3%

Poland

187

552%

2%

Tajikistan

176

NA

2%

Lithuania

115

58%

2%

Kazakhstan

93

-35%

1%

Albania

77

NA

1%

Other

502

-47%

7%

Total

7 627

-5%

100%

According to preliminary unconsolidated results, sales of JSC Olainfarm in ten months of 2017 reached 76.04 million euros, which represents an increase by 3% compared to ten months of 2016. The biggest sales increase during this period was achieved in Germany, where sales grew by 116%. Sales to The Netherlands increased by 92%. Biggest sales reduction was experienced in Ukraine, where it shrunk by 36%. Biggest sales markets of JSC Olainfarm during this period were Russia, Latvia, Ukraine and Belarus. In total in ten months of 2017, JSC Olainfarm sold its products to 50 countries in five continents.

10 months of 2017, unconsolidated sales

Sales, thsnd. EUR

Changes to ten months of 2016

Share in total sales

Russia

29 096

10%

38%

Latvia

12 043

9%

16%

Ukraine

8 352

-36%

11%

Belarus

8 120

19%

11%

The Netherlands

3 831

92%

5%

Kazakhstan

1 868

0%

2%

Germany

1 528

116%

2%

Uzbekistan

1 397

-33%

2%

Lithuania

1 047

18%

1%

Turkmenistan

1 023

-4%

1%

Other

7 738

-4%

10%

Total

76 043

3%

100%

General meeting of shareholders of JSC Olainfarm held on June 1, 2017 approved operating plan of the company, providing that unconsolidated sales of the company in 2017 will reach 96 million euros, while consolidated sales of the company will reach 127 million euros. According to these preliminary sales numbers, in ten months of 2017 the company has met 79% of annual target for unconsolidated sales and 75% of annual target for consolidated sales.

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 50 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

Preliminary consolidated results of JSC Olainfarm for September 2017 show that sales made during this month reached 9.63 million euros, which represents an increase by 17% compared to September 2016. The biggest sales increase was achieved in Uzbekistan, where sales grew by 388%. Sales to Albania grew by 232%, sales to Germany grew by 159%, sales to Russia grew by 69% but sales to Ukraine increased by 54%. The biggest sales reduction happened in The Netherlands, where sales shrunk by 73%. Major sales markets of the Group during September 2017 were Russia, Latvia, Ukraine and Belarus.

September 2017, consolidated sales

Sales, thsnd. EUR

Changes to September 2016

Share in total sales

Russia

3 447

69%

36%

Latvia

2 728

13%

28%

Ukraine

1 021

54%

11%

Belarus

674

24%

7%

Kazakhstan

375

-18%

4%

The Netherlands

146

-73%

2%

Uzbekistan

144

388%

1%

Lithuania

141

37%

1%

Germany

129

159%

1%

Albania

111

232%

1%

Other

712

-46%

7%

Total

9 628

17%

100%

Sales of pharmacies of Latvijas aptieka during September 2017 were 1.94 million euros, which represents an increase by 21% compared to September 2016. Sixty-nine pharmacies were operating during this period. Sales of Silvanols in September 2017 were 0.55 million euros, which represents a reduction by 13% compared to the same period of last year. During September 2017, Silvanols sold its products in four European countries and with the mediation of JSC Olainfarm also to Kazakhstan, Lithuania, Belarus, Russia, Armenia, Mongolia and Azerbaijan. Sales of Tonus Elast in September reached 0.74 million euros, which represents an increase by 40% compared to September 2016. Its products were sold to 16 countries in three continents.

According to preliminary consolidated results, sales of JSC Olainfarm group in nine months of 2017 reached 85.61 million euros, which represents an increase by 9% compared to nine months of 2016. The biggest sales increase during this period was achieved in Germany, where sales grew by 200%, but sales to The Netherlands increased by 133%. The biggest sales reduction was experienced in Ukraine where sales shrunk by 39%. Major sales markets of JSC Olainfarm group in nine months of 2017 were Russia, Latvia, Belarus and Ukraine.

9 months of 2017, consolidated sales

Sales, thsnd. EUR

Changes to 9 months of 2016

Share in total sales

Russia

28 382

23%

33%

Latvia

21 611

13%

25%

Belarus

7 696

22%

9%

Ukraine

7 412

-39%

9%

The Netherlands

3 814

133%

4%

Kazakhstan

2 640

30%

3%

Uzbekistan

1 397

-22%

2%

Germany

1 305

200%

2%

Lithuania

1 129

18%

1%

Turkmenistan

1 023

-4%

1%

Other

9 200

-8%

11%

Total

85 609

9%

100%

Sales of pharmacies of Latvijas aptieka in nine months of 2017 reached 15.7 million euros, which represents an increase by 13% compared to nine months of 2016. Sales of Silvanols in nine months reached 3.89 million euros, which represents an increase by 6% compared to 9 months of 2016. Products of Silvanols were sold to twelve European countries and with the help of JSC Olainfarm also to Kazakhstan, Lithuania, Belarus, Russia, Armenia, Mongolia and Azerbaijan. Sales of Tonus Elast in nine months reached 6.17 million euros and its products were sold to 37 countries in four continents.

According to preliminary unconsolidated results, sales of JSC Olainfarm in September 2017 were 7.55 million euros, which represents an increase by 17% compared to September 2016. The biggest sales increase was achieved in Uzbekistan, where sales grew by 388%. Sales to Albania increased by 232%, sales to Germany increased by 161%, sales to Lithuania increases by 81%, sales to Ukraine increased by 63% and sales to Russia increased by 59%. Biggest sales reduction was experienced in the Netherlands, where sales shrunk by 73% and in Kazakhstan, where sales shrunk by 69%. Biggest sales markets during September 2017 were Russia, Latvia, Ukraine and Belarus. During September 2017, products of JSC Olainfarm were sold to 32 countries in Asia and Europe.

September 2017, unconsolidated sales

Sales, thsnd. EUR

Changes to September 2016

Share in total sales

Russia

3 255

59%

43%

Latvia

1 334

9%

18%

Ukraine

1 021

63%

14%

Belarus

674

24%

9%

The Netherlands

146

-73%

2%

Uzbekistan

144

388%

2%

Lithuania

135

81%

2%

Germany

129

161%

2%

Kazakhstan

121

-69%

2%

Albania

111

232%

1%

Other

482

-46%

6%

Total

7 552

17%

100%

According to preliminary unconsolidated results of JSC Olainfarm for nine months of 2017, sales of the company during this period reached 68.42 million euros, which represents an increase by 4% compared to nine months of 2016. The biggest sales increase was achieved in Germany, where sales increased by 202% and in The Netherlands, where sales grew by 133%. Biggest sales reduction was experienced in Ukraine, where sales shrunk by 40%. Major sales markets of JSC Olainfarm during this period were Russia, Latvia, Belarus and Ukraine. In total, during nine months of 2017, products of JSC Olainfarm were sold to 48 countries in five continents.

9 months of 2017, unconsolidated sales

Sales, thsnd. EUR

Changes to nine months of 2016

Share in total sales

Russia

25 946

15%

38%

Latvia

10 602

7%

15%

Belarus

7 602

21%

11%

Ukraine

7 228

-40%

11%

The Netherlands

3 814

133%

6%

Kazakhstan

1 774

3%

3%

Uzbekistan

1 397

-22%

2%

Germany

1 292

202%

2%

Turkmenistan

1 023

-4%

1%

Italy

954

36%

1%

Other

6 789

-14%

10%

Total

68 421

4%

100%

General meeting of shareholders of JSC Olainfarm held on June 1, 2017 approved operating plan of the company, providing that unconsolidated sales of the company in 2017 will reach 96 million euros, while consolidated sales of the company will reach 127 million euros. According to these preliminary sales numbers, in nine months of 2017 the company has met 71% of annual target for unconsolidated sales and 67% of annual target for consolidated sales.

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 50 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

Preliminary consolidated results of Olainfarm for August 2017 show that sales of the group reached 8.04 million euros, which represents an increase by 19% compared to August of 2016. The biggest sales increase was achieved in Tajikistan, where sales grew by 349%. Sales to Germany grew by 110%; sales to Russia grew by 93%, sales to Belarus increased by 63%. Biggest sales reduction happened in Ukraine where sales shrunk by 49%. During August 2017, the Group also made significant shipments to Turkmenistan and The Netherlands. Major sales markets of the group during this period were Russia, Latvia and Belarus.

August 2017, consolidated sales

Sales, thsnd. EUR

Changes to August 2016

Share in total sales

Russia

2 633

93%

33%

Latvia

2 342

7%

29%

Belarus

807

63%

10%

Ukraine

493

-49%

6%

Kazakhstan

245

17%

3%

Uzbekistan

216

-28%

3%

Turkmenistan

194

NA

2%

Germany

159

110%

2%

The Netherlands

120

NA

1%

Tajikistan

101

349%

1%

Other

727

-37%

9%

Total

8 037

19%

100%

Sales of pharmacies of Latvijas Aptieka during August 2017 were 1.83 million euros, which represents an increase by 24% compared to August 2016. Sixty-eight pharmacies were operating during this period. Sales of Silvanols during August were 0.38 million euros, which represents an increase by 6% compared to 2016. In August 2017, Silvanols sold its products in seven European countries and, with the assistance from JSC Olainfarm to Kazakhstan, Belarus and Russia. Sales of Tonus Elast during August 2017 reached .73 million euros, which represents a reduction by 4% compared to August 2016. Products of Tonus Elast were sold to 19 countries in three continents.

According to preliminary numbers, consolidated sales of Olainfarm group in eight months of 2017 reached 76.39 million euros, which represents an increase by 9% compared to eight months of 2016. The biggest sales increase was achieved in The Netherlands, where sales grew by 236%. Sales to Germany increased by 206%, sakes to Kazakhstan increased by 44% but sales to Italy increased by 43%. Biggest reduction of sales took place in Ukraine, where sales shrunk by 44%. Major sales markets of Olainfarm group in eight months were Russia, Latvia, Belarus and Ukraine.

8 months of 2017, consolidated sales

Sales, thsnd. EUR

Changes to 8 months of 2016

Share in total sales

Russia

24 935

19%

33%

Latvia

19 306

17%

25%

Belarus

7 023

22%

9%

Ukraine

6 391

-44%

8%

The Netherlands

3 668

236%

5%

Kazakhstan

2 265

44%

3%

Uzbekistan

1 253

-28%

2%

Germany

1 176

206%

2%

Turkmenistan

1 023

-4%

1%

Italy

1 003

43%

1%

Other

8 347

-9%

11%

Total

76 390

9%

100%

Sales of pharmacies of Latvijas aptieka in eight months of 2017 were 13.8 million euros, which represents an increase by 12% compared to eight months of 2016. Sales of Silvanols during this period were 3.3 million euros, which represents an increase by 6% compared to eight months of 2016 when this company made sales of 3.1 million euros. Products of Silvanols were sold to twelve European countries and with the help from JSC Olainfarm to Lithuania, Russia, Azerbaijan, Belarus, Kazakhstan and Armenia. Sales of Tonus Elast in eight months were 5.4 million euros and its products were sold to 37 countries in four continents.

According to unconsolidated preliminary results, sales of JSC Olainfarm in August 2017 were 6.07 million euros, which represents an increase by 24% compared to August of 2016. The biggest sales increase was achieved in Tajikistan, where sales grew by 349%. Sales to Germany increased by 112%, sale to Russia increased by 66%, sales to Kazakhstan increased by 65% but sales to Belarus increased by 61%. The biggest sales reduction took place in Ukraine, where sales shrunk by 58%. During August 2017, JSC Olainfarm also made significant shipments to Turkmenistan and The Netherlands. Major sales markets of JSC Olainfarm during this period were Russia, Latvia, Belarus and Ukraine. In august 2017, products of JSC Olainfarm were sold to 25 countries in two continents.

August 2017, unconsolidated sales

Sales, thsnd. EUR

Changes to August 2016

Share in total sales

Russia

2 267

66%

37%

Latvia

1 108

6%

18%

Belarus

778

61%

13%

Ukraine

402

-58%

7%

Uzbekistan

216

-28%

4%

Kazakhstan

200

65%

3%

Turkmenistan

194

NA

3%

Germany

155

112%

3%

The Netherlands

120

NA

2%

Tajikistan

101

349%

2%

Other

533

4%

9%

Total

6 074

24%

100%

According to preliminary unconsolidated results, sales of JSC Olainfarm in eight months of 2017 were 60.87 million euros, which represents and increase by 2% compared to the same period one year ago. The biggest sales increase during this period was achieved in The Netherlands, where sales increased by 249%, while sales to Germany increased by 207%. Biggest sales reduction was experienced in Ukraine, where sales shrunk by 46%. Major sales markets of JSC Olainfarm during these eight months were Russia, Latvia, Belarus and Ukraine. In total during this eight months period JSC Olainfarm sold its products to 46 countries in five continents.

Eight months of 2017, unconsolidated sales

Sales, thsnd. EUR

Changes to 8 months of 2016

Share in total sales

Russia

22 691

10%

37%

Latvia

9 271

7%

15%

Belarus

6 929

21%

11%

Ukraine

6 207

-46%

10%

The Netherlands

3 668

249%

6%

Kazakhstan

1 654

24%

3%

Uzbekistan

1 253

-28%

2%

Germany

1 163

207%

2%

Turkmenistan

1 023

-4%

2%

Italy

953

36%

2%

Other

6 061

-13%

10%

Total

60 873

2%

100%

General meeting of shareholders of JSC Olainfarm held on June 1, 2017 approved operating plan of the company, providing that unconsolidated sales of the company in 2017 will reach 96 million euros, while consolidated sales of the company will reach 127 million euros. According to these preliminary sales numbers, in eight months of 2017 the company has met 63% of annual target for unconsolidated sales and 60% of annual target for consolidated sales.

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 40 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

On September 11 JSC Olainfarm organized its Investor Conference Online Webinar. During the webinar the member of the management board of JSC Olainfarm Salvis Lapiņš analyzed the financial results of second quarter 2017 and informed about the other recent activities within the company.

The recorded JSC Olainfarm webinar is available online: ej.uz/OLF_Q22017_rec, and the presentation, demonstrated during the webinar, is available in the previously published company’s announcement: ej.uz/OLF_Q22017_EN.
Olainfarm thanks all participants, who joined the webinar, and encourages everybody to follow company’s announcements to get information on the next webinar!

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 40 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

Webinar will be hosted by the Member of the Management Board Salvis Lapiņš. The presentation will be held in English.

During the webinar Salvis Lapiņš will inform about JSC Olainfarm latest activities and analyze the financial results of the second quarter 2017. After the presentation investors are welcome to ask questions.

Among other things, Mr Lapiņš will inform about the updated profit forecast for 2017 for the Company and the Group. The management now expects that unconsolidated profit of Olainfarm will reach 11 million euros, while consolidated profit will be around 13.5 million euros. These projections are based on assumption that foreign exchange fluctuations will not leave any important impact on profitability.

What is a webinar?
Webinar is a virtual conference, during which company’s representative gives information about the company, its activities and future plans. Webinar allows interactive communication and provides an opportunity to ask questions and get answers directly from the company.

How to join the webinar?
All you need is a computer with internet connection and headphones.

You will be provided with the webinar link and instructions to join webinar successfully. When joining the webinar for the first time, you will be asked to download the system application on your computer which will take only few seconds.

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 40 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.